CUMBERLAND PHARMACEUTICALS INC - COM (CPIX)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
2.08M
Holdings value Q2 2024
$3.18M
Value change Q2 2024
-$134K
Grand Portfolio weight change Q2 2024
0%
Number of holders
22
Number of buys Q2 2024
6
Number of sells Q2 2024
-8
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 2.08M $3.18M -$134K $1.53 22
2024 Q1 2.16M $3.63M -$59.4K $1.68 22
2023 Q4 2.2M $3.89M -$17.6K $1.79 23
2023 Q3 2.21M $4.17M -$311K $1.89 20
2023 Q2 2.4M $3.52M -$75.7K $1.47 21
2023 Q1 2.45M $4.77M -$93K $1.95 21
2022 Q4 2.49M $5.61M +$78.5K $2.25 22
2022 Q3 2.45M $5.89M -$556K $2.41 15
2022 Q2 2.71M $5.62M -$447K $2.08 22
2022 Q1 2.9M $8.17M -$99.6K $2.82 26
2021 Q4 2.84M $13.2M +$376K $4.67 24
2021 Q3 2.77M $7.43M -$468K $2.68 20
2021 Q2 2.94M $8.36M -$813K $2.84 24
2021 Q1 3.22M $9.77M -$1.95M $3.03 27
2020 Q4 3.88M $11.4M -$522K $2.95 24
2020 Q3 4.03M $12.9M -$361K $3.21 22
2020 Q2 4.14M $13.8M -$1.83M $3.33 23
2020 Q1 4.67M $17M +$754K $3.63 21
2019 Q4 4.46M $23M -$197K $5.15 23
2019 Q3 4.48M $26.6M -$1.73M $5.93 26
2019 Q2 4.77M $30.4M -$985K $6.37 22
2019 Q1 4.92M $28.6M -$353K $5.81 22
2018 Q4 4.98M $30.5M -$2.11M $6.03 22
2018 Q3 5.36M $30.6M -$33.8K $5.71 30
2018 Q2 5.37M $32.9M -$466K $6.13 29
2018 Q1 5.43M $36.2M -$49.5K $6.68 29
2017 Q4 5.43M $40.1M +$84.3K $7.36 31
2017 Q3 5.42M $38.3M -$194K $7.06 31
2017 Q2 5.45M $38.3M -$396K $7.00 34
2017 Q1 5.51M $38.2M +$3.1M $6.94 36
2016 Q4 5.48M $30.1M +$364K $5.50 38
2016 Q3 5.42M $27.1M +$889K $5.00 40
2016 Q2 5.24M $23.6M +$116K $4.50 40
2016 Q1 5.22M $23.4M -$99.2K $4.49 46
2015 Q4 5.13M $27M -$413K $5.26 43
2015 Q3 5.15M $29.7M +$52.6K $5.77 44
2015 Q2 5.2M $37.2M -$1.83M $7.15 44
2015 Q1 5.47M $36.4M -$1.52M $6.66 43
2014 Q4 5.72M $34.2M -$3.79M $5.98 42
2014 Q3 6.36M $31.4M -$1.43M $4.94 44
2014 Q2 6.67M $30M -$216K $4.50 44
2014 Q1 6.72M $30.2M +$107K $4.50 46